1. Esposito S, Stefanelli P, Fry NK, et al. World Association of Infectious Diseases and Immunological Disorders (WAidid) and the Vaccine Study Group of the European Society of Clinical Microbiology and Infectious Diseases (EVASG). Pertussis prevention: reasons for resurgence, and differences in the current acellular pertussis vaccines. Front Immunol. 2019;10:1344.
2. Adams DA, Gallagher KM, Jajosky RA, et al, Division of Notifiable Diseases and Healthcare Information. Office of Surveillance, Epidemiology, and Laboratory Services, CDC. Summary of notifiable diseases ̶ United States, 2011. MMWR Morb Mortal Wkly Rep. 2013;60:1–117.
3. Centers for Disease Control and Prevention (CDC). Jajosky RA, Hall PA, Adams DA, et al. Summary of notifiable diseases ̶ United States, 2004. MMWR Morb Mortal Wkly Rep. 2006;53:1–79.
4. McIntyre P, Gidding H, Gilmour R, et al; National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases. Vaccine preventable diseases and vaccination coverage in Australia, 1999 to 2000. Commun Dis Intell Q Rep. 2002;Suppl:i-xi, 1–111.
5. Chasaide CN, Mills KHG. Next-generation pertussis vaccines based on the induction of protective T cells in the respiratory tract. Vaccines (Basel). 2020;8:621.